Loretta Itri

Loretta joined Aadi in October 2021 as the Chief Medical Officer. She was most recently the Chief Medical Officer at Immunomedics, and before that, Executive Vice President of Global Health Sciences & Regulatory Affairs at The Medicines Company. Previously, she was president of Pharmaceutical Development and CMO at Genta, Inc., Prior to that, Dr. Itri served as Senior Vice President of Medical and Regulatory Affairs at Johnson & Johnson’s Pharmaceutical Research Institute. In addition, she served as Senior Vice President of Clinical Affairs and CMO for Ortho Biotech Inc. Dr. Itri began her career at Hoffmann-La Roche, as Assistant Vice President of Clinical Development in immunology and oncology. Dr. Itri received her M.D. from New York Medical College, completed her medical residency at SUNY-Stony Brook, and her fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center where she was an adjunct attending physician for more than 15 years. Dr. Itri has served as a member of the National Cancer Institute Board of Scientific Counselors and has published extensively on the development of therapeutic agents.